Angiotensin converting enzyme inhibitors: differences and advantages for first line therapy in hypertension

scientific article

Angiotensin converting enzyme inhibitors: differences and advantages for first line therapy in hypertension is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.3109/10641968909035394
P698PubMed publication ID2676252

P2093author name stringJohnston CI
P2860cites workNovel activity of human angiotensin I converting enzyme: release of the NH2- and COOH-terminal tripeptides from the luteinizing hormone-releasing hormoneQ24294678
Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).Q34682919
Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsQ34936463
Kinin effects on chloride secretion do not require eicosanoid synthesisQ36004073
Tissue-specific expression of mRNAs for dipeptidyl carboxypeptidase isoenzymesQ36304227
Captopril in heart failure. A double blind controlled trialQ36753945
Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertensionQ36994591
Angiotensin-converting enzyme inhibitors: past, present, and bright futureQ39343506
Recent developments in the design of angiotensin-converting enzyme inhibitorsQ39497847
Angiotensin-converting enzyme inhibitors: Medicinal chemistry and biological actionsQ40130622
Angiotensin converting enzyme in rat brain visualized by quantitative in vitro autoradiographyQ42509888
Enalapril (MK421) activation in man: importance of liver statusQ42530755
The effects of antihypertensive therapy on the quality of lifeQ43484013
Inhibition of tissue angiotensin converting enzyme. Quantitation by autoradiographyQ48109312
P433issue5-6
P304page(s)1097-1115
P577publication date1989-01-01
P1433published inClinical and Experimental HypertensionQ5133806
P1476titleAngiotensin converting enzyme inhibitors: differences and advantages for first line therapy in hypertension
P478volume11

Reverse relations

cites work (P2860)
Q40395221Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders
Q36657490Quinapril. A review of its pharmacological properties, and therapeutic efficacy in cardiovascular disorders

Search more.